Johnson & Johnson (JNJ) begins on Tuesday its third attempt to push through a multi-billion-dollar settlement relating to ...

In a report released today, Josh Jennings from TD Cowen maintained a Buy rating on Johnson & Johnson (JNJ – Research Report), with a price ...

Bright Futures Wealth Management LLC. cut its holdings in Johnson & Johnson (NYSE:JNJ – Free Report) by 55.1% in the 4th ...

Johnson & Johnson is well-diversified across thriving healthcare segments, with promising FDA approvals. Read why I assign a ...

Equities researchers at Zacks Research lifted their Q2 2025 earnings estimates for Johnson & Johnson in a note issued to ...

J&J JNJ stock has risen more than 6% in the past month. The reason behind the increase was a strong-than-expected ...

Large American pharmaceutical companies are showing a distinct trend never seen before: they are increasingly looking for ...

We recently compiled a list of the 13 Best Forever Stocks to Buy Right Now. In this article, we are going to take a look at ...

Jim Cramer, the host of Mad Money, cautioned viewers on Wednesday about the risks of blindly following the crowd in the stock ...

GMO's portfolio update highlights key stock adjustments and forecasts a promising 9.6% return for International Deep Value ...